Catherine Hales, after using Mounjaro for weight loss, is facing gallbladder removal due to gallstones and pancreatitis. She lost three stone, but the experience led to severe abdominal pain and frequent emergency room visits. This outcome highlights potential health risks associated with rapid weight loss, a known side effect of these medications.

Rapid weight loss, a common side effect of GLP-1 medications, is statistically linked to an increase in gallbladder surgeries. The NHS England recorded a peak in these surgeries in 2024-25. While the direct link between GLP-1s and gallstones is still under investigation, the experience underscores the importance of monitoring health during weight loss programs.

Hales' experience raises questions about the long-term effects of weight loss drugs, prompting a need for more research into the relationship between GLP-1 medications and gallbladder issues. It also highlights the complexities of weight management and the importance of considering potential health trade-offs.

Experts are urging further investigation into the potential risks associated with rapid weight loss induced by GLP-1 medications like Mounjaro. The story also underscores the importance of consulting with healthcare professional and carefully considering potential side effects before starting any weight loss journey.